Deira Trading Company

FDA says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the U.S. Food and Drug Administration said Friday.  The FDA’s decision will threaten the […]

Bluebird Bio gene therapy sells itself to Carlyle and SK Capital

Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. […]

Home sales drop sharply in January as prices hit high

A “For Sale” sign on a house in Philadelphia, Pennsylvania, US, on Friday, Aug. 16, 2024.  Joe Lamberti | Bloomberg | Getty Images The U.S. housing market continues to weaken, as potential buyers face stubbornly high mortgage rates, high prices and limited supply of listings. Sales of previously-owned homes fell 4.9% in January from the […]

Eli Lilly Dan Skovronsky discusses weight loss drugs

Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a shot that could be even more powerful than Zepbound. And […]

Amazon wins creative control of James Bond franchise from Broccoli family

Daniel Craig stars as James Bond in “No Time To Die.” Source: MGM Amazon is set to take creative control over the lucrative James Bond movie franchise from the Broccoli family, the company announced Thursday. The James Bond films have long been produced by Michael Wilson and Barbara Broccoli, who inherited the control from their […]

Hasbro (HAS) earnings Q4 2024

Toy and gaming giant Hasbro took an optimistic tone Thursday on the potential effect of Chinese tariffs on its business, as executives said the company is shifting manufacturing away from China. Hasbro Chief Financial Officer Gina Goetter said on the company’s fourth-quarter earnings call that the toymaker’s 2025 guidance — which includes adjusted EBITDA of […]

Source: CurrencyRate